Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flucloxacillin 250mg/5ml oral suspension
0501012H0AAABAB
|
Flucloxacillin magesium | Flucloxacillin magnesium | Infections | 1 |
|
Fluconazole 200mg/100ml solution for infusion bottles
0502010B0AAALAL
|
Fluconazole | Fluconazole | Infections | 1 |
|
Fluconazole 50mg/25ml solution for infusion vials
0502010B0AAADAD
|
Fluconazole | Fluconazole | Infections | 1 |
|
Genfura 100mg tablets
0501130R0BHAAAE
|
Genfura | Nitrofurantoin | Infections | 1 |
|
Genfura 50mg tablets
0501130R0BHABAD
|
Genfura | Nitrofurantoin | Infections | 1 |
|
Griseofulvin 250mg/5ml oral suspension
0502050B0AAARAR
|
Griseofulvin (Systemic) | Griseofulvin | Infections | 1 |
|
Itraconazole 50mg/5ml oral liquid
0502010C0AAACAC
|
Itraconazole | Itraconazole | Infections | 1 |
|
Klaricid Paediatric 250mg/5ml oral suspension
0501050B0BBAHAH
|
Klaricid | Clarithromycin | Infections | 1 |
|
Lamivudine 300mg tablets
0503010Q0AAAEAE
|
Lamivudine | Lamivudine | Infections | 1 |
|
Levamisole 50mg/5ml oral suspension
0505020L0AAAGAG
|
Levamisole hydrochloride | Levamisole hydrochloride | Infections | 1 |
|
Macrodantin 50mg capsules
0501130R0BCAAAA
|
Macrodantin | Nitrofurantoin | Infections | 1 |
|
Maloff Protect 250mg/100mg tablets
0504010U0BEAAAA
|
Maloff Protect | Proguanil hydrochloride with atovaquone | Infections | 1 |
|
Metronidazole 500mg/100ml infusion 100ml bags
0501110C0AABABA
|
Metronidazole (Systemic) | Metronidazole | Infections | 1 |
|
Minocin 100mg tablets
0501030P0BBABAB
|
Minocin | Minocycline hydrochloride | Infections | 1 |
|
Nevirapine 200mg tablets
0503010B0AAAAAA
|
Nevirapine | Nevirapine | Infections | 1 |
|
Nitrofurantoin 12.5mg/5ml oral liquid
0501130R0AABEBE
|
Nitrofurantoin | Nitrofurantoin | Infections | 1 |
|
Nitrofurantoin 125mg/5ml oral liquid
0501130R0AABSBS
|
Nitrofurantoin | Nitrofurantoin | Infections | 1 |
|
Norfloxacin 400mg tablets
0501120Q0AAAAAA
|
Norfloxacin (Systemic) | Norfloxacin | Infections | 1 |
|
Odefsey 200mg/25mg/25mg tablets
050301000BBAFA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 1 |
|
Praziquantel 500mg tablets
0505050P0AAABAB
|
Praziquantel | Praziquantel | Infections | 1 |
|
Primaquine 7.5mg tablets
0504010K0AAAAAA
|
Primaquine | Primaquine | Infections | 1 |
|
Pristinamycin 500mg tablets
0501070Z0AAAAAA
|
Pristinamycin | Pristinamycin | Infections | 1 |
|
Promixin 1million unit inj vials
0501070I0BCABAB
|
Promixin | Colistimethate sodium | Infections | 1 |
|
Raltegravir 600mg tablets
0503010AEAAAEAE
|
Raltegravir | Raltegravir | Infections | 1 |
|
Ranovir 800mg tablets
0503021C0BEACAD
|
Ranovir | Aciclovir | Infections | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.